+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Cell Lysis/Cell Fractionation Market Research Report by Product (Consumables and Instruments), Cell Type, Application, End-user, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 244 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 5324595
UP TO OFF until Dec 31st 2022
The Global Cell Lysis/Cell Fractionation Market size was estimated at USD 2,857.61 million in 2021, USD 3,094.01 million in 2022, and is projected to grow at a CAGR 8.44% to reach USD 4,649.13 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Cell Lysis/Cell Fractionation to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market was studied across Consumables and Instruments. The Consumables is further studied across Beads, Disposables, and Reagents & Kits. The Instruments is further studied across Homogenizers and Sonicators.
  • Based on Cell Type, the market was studied across Mammalian Cells and Microbial Cells.
  • Based on Application, the market was studied across Nucleic Acid Purification & Isolation and Protein Purification & Isolation.
  • Based on End-user, the market was studied across Biopharmaceutical & Biotechnology Companies and Research Laboratories & Institutes.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Cell Lysis/Cell Fractionation market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cell Lysis/Cell Fractionation Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Cell Lysis/Cell Fractionation Market, including Agilent Technologies, Beckman Coulter, Becton, Dickinson and Company, Bio-Rad Laboratories, Biovision, Cell Signaling Technology, Claremont Biosolutions, Covaris, G-Biosciences (Geno Technology), Labfreez Instruments Group, Merck, Microfluidics International Corporation, Miltenyi Biotec, Norgen Biotek Corp., Nzytech, Parr Instrument Company, Promega Corporation, Promocell, Qiagen, Qsonica, Roche Diagnostics, Stemcell Technologies, Takara Bio, and Thermo Fisher Scientific.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Cell Lysis/Cell Fractionation Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cell Lysis/Cell Fractionation Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cell Lysis/Cell Fractionation Market?
4. What is the competitive strategic window for opportunities in the Global Cell Lysis/Cell Fractionation Market?
5. What are the technology trends and regulatory frameworks in the Global Cell Lysis/Cell Fractionation Market?
6. What is the market share of the leading vendors in the Global Cell Lysis/Cell Fractionation Market?
7. What modes and strategic moves are considered suitable for entering the Global Cell Lysis/Cell Fractionation Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Expanding healthcare, life sciences, and pharmaceutical industries research and developmental activities in countless fields
5.1.1.2. Increasing government funding for research
5.1.1.3. Increasing cases of diseases and diagnostics
5.1.2. Restraints
5.1.2.1. High cost of cell-based equipments and researches
5.1.2.2. Shortage of trained personnel
5.1.3. Opportunities
5.1.3.1. Growing focus on personalized medicine, and the expansion of biopharmaceutical and biotechnology industries
5.1.3.2. Growing prevalence of diseases such as HIV/AIDS and cancer
5.1.4. Challenges
5.1.4.1. Survival of small players and addition of new technological advancement routinely
5.2. Cumulative Impact of COVID-19
6. Cell Lysis/Cell Fractionation Market, by Product
6.1. Introduction
6.2. Consumables
6.2.1. Beads
6.2.2. Disposables
6.2.3. Reagents & Kits
6.3. Instruments
6.3.1. Homogenizers
6.3.2. Sonicators
7. Cell Lysis/Cell Fractionation Market, by Cell Type
7.1. Introduction
7.2. Mammalian Cells
7.3. Microbial Cells
8. Cell Lysis/Cell Fractionation Market, by Application
8.1. Introduction
8.2. Nucleic Acid Purification & Isolation
8.3. Protein Purification & Isolation
9. Cell Lysis/Cell Fractionation Market, by End-user
9.1. Introduction
9.2. Biopharmaceutical & Biotechnology Companies
9.3. Research Laboratories & Institutes
10. Americas Cell Lysis/Cell Fractionation Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cell Lysis/Cell Fractionation Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
12. Europe, Middle East & Africa Cell Lysis/Cell Fractionation Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Agilent Technologies
14.2. Beckman Coulter
14.3. Becton, Dickinson and Company
14.4. Bio-Rad Laboratories
14.5. Biovision
14.6. Cell Signaling Technology
14.7. Claremont Biosolutions
14.8. Covaris
14.9. G-Biosciences (Geno Technology)
14.10. Labfreez Instruments Group
14.11. Merck
14.12. Microfluidics International Corporation
14.13. Miltenyi Biotec
14.14. Norgen Biotek Corp.
14.15. Nzytech
14.16. Parr Instrument Company
14.17. Promega Corporation
14.18. Promocell
14.19. Qiagen
14.20. Qsonica
14.21. Roche Diagnostics
14.22. Stemcell Technologies
14.23. Takara Bio
14.24. Thermo Fisher Scientific
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET DYNAMICS
FIGURE 8. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 9. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2027
FIGURE 11. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY BEADS, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY BEADS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY DISPOSABLES, 2019-2027 (USD MILLION)
FIGURE 16. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY DISPOSABLES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY REAGENTS & KITS, 2019-2027 (USD MILLION)
FIGURE 18. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2019-2027 (USD MILLION)
FIGURE 20. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 21. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY HOMOGENIZERS, 2019-2027 (USD MILLION)
FIGURE 22. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY HOMOGENIZERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 23. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY SONICATORS, 2019-2027 (USD MILLION)
FIGURE 24. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY SONICATORS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 25. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2021 VS 2027 (%)
FIGURE 26. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2027
FIGURE 28. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY MAMMALIAN CELLS, 2019-2027 (USD MILLION)
FIGURE 29. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY MAMMALIAN CELLS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 30. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY MICROBIAL CELLS, 2019-2027 (USD MILLION)
FIGURE 31. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY MICROBIAL CELLS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 32. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 33. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2027
FIGURE 35. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY NUCLEIC ACID PURIFICATION & ISOLATION, 2019-2027 (USD MILLION)
FIGURE 36. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY NUCLEIC ACID PURIFICATION & ISOLATION, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 37. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PROTEIN PURIFICATION & ISOLATION, 2019-2027 (USD MILLION)
FIGURE 38. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PROTEIN PURIFICATION & ISOLATION, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 39. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2021 VS 2027 (%)
FIGURE 40. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2021 VS 2027 (USD MILLION)
FIGURE 41. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2027
FIGURE 42. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2019-2027 (USD MILLION)
FIGURE 43. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 44. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY RESEARCH LABORATORIES & INSTITUTES, 2019-2027 (USD MILLION)
FIGURE 45. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 46. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 47. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 48. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 49. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2027
FIGURE 50. ARGENTINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. BRAZIL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. CANADA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. MEXICO CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 56. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 57. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY STATE, 2027
FIGURE 58. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 60. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 61. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2027
FIGURE 62. AUSTRALIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. CHINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. INDIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. INDONESIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. JAPAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. MALAYSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 68. PHILIPPINES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 69. SINGAPORE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 70. SOUTH KOREA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. TAIWAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 72. THAILAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 73. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 74. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 75. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 76. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2027
FIGURE 77. FRANCE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 78. GERMANY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 79. ITALY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 80. NETHERLANDS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 81. QATAR CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 82. RUSSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 83. SAUDI ARABIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 84. SOUTH AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 85. SPAIN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 86. UNITED ARAB EMIRATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 87. UNITED KINGDOM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 88. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 89. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 90. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 6. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, BY REGION, 2019-2027 (USD MILLION)
TABLE 7. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY BEADS, BY REGION, 2019-2027 (USD MILLION)
TABLE 12. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY BEADS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY BEADS, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY BEADS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY BEADS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY DISPOSABLES, BY REGION, 2019-2027 (USD MILLION)
TABLE 17. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY DISPOSABLES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY DISPOSABLES, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY DISPOSABLES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY DISPOSABLES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2019-2027 (USD MILLION)
TABLE 22. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY REAGENTS & KITS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 23. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY REAGENTS & KITS, BY STATE, 2019-2027 (USD MILLION)
TABLE 24. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY REAGENTS & KITS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY REAGENTS & KITS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 27. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 28. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 29. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY HOMOGENIZERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 32. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY HOMOGENIZERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 33. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY HOMOGENIZERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 34. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY HOMOGENIZERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY HOMOGENIZERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY SONICATORS, BY REGION, 2019-2027 (USD MILLION)
TABLE 37. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY SONICATORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 38. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY SONICATORS, BY STATE, 2019-2027 (USD MILLION)
TABLE 39. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY SONICATORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY SONICATORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2019-2027 (USD MILLION)
TABLE 42. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY MAMMALIAN CELLS, BY REGION, 2019-2027 (USD MILLION)
TABLE 43. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY MAMMALIAN CELLS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 44. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY MAMMALIAN CELLS, BY STATE, 2019-2027 (USD MILLION)
TABLE 45. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY MAMMALIAN CELLS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 46. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY MAMMALIAN CELLS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 47. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY MICROBIAL CELLS, BY REGION, 2019-2027 (USD MILLION)
TABLE 48. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY MICROBIAL CELLS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 49. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY MICROBIAL CELLS, BY STATE, 2019-2027 (USD MILLION)
TABLE 50. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY MICROBIAL CELLS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY MICROBIAL CELLS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 52. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 53. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY NUCLEIC ACID PURIFICATION & ISOLATION, BY REGION, 2019-2027 (USD MILLION)
TABLE 54. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY NUCLEIC ACID PURIFICATION & ISOLATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 55. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY NUCLEIC ACID PURIFICATION & ISOLATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 56. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY NUCLEIC ACID PURIFICATION & ISOLATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY NUCLEIC ACID PURIFICATION & ISOLATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 58. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PROTEIN PURIFICATION & ISOLATION, BY REGION, 2019-2027 (USD MILLION)
TABLE 59. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PROTEIN PURIFICATION & ISOLATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 60. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PROTEIN PURIFICATION & ISOLATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 61. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PROTEIN PURIFICATION & ISOLATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 62. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PROTEIN PURIFICATION & ISOLATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 63. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 64. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 65. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 66. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 67. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 69. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2019-2027 (USD MILLION)
TABLE 70. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 71. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY RESEARCH LABORATORIES & INSTITUTES, BY STATE, 2019-2027 (USD MILLION)
TABLE 72. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 74. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 75. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 76. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 77. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2019-2027 (USD MILLION)
TABLE 78. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 79. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 80. ARGENTINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 81. ARGENTINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 82. ARGENTINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2019-2027 (USD MILLION)
TABLE 83. ARGENTINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 84. ARGENTINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 85. BRAZIL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 86. BRAZIL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 87. BRAZIL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2019-2027 (USD MILLION)
TABLE 88. BRAZIL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 89. BRAZIL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 90. CANADA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 91. CANADA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 92. CANADA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2019-2027 (USD MILLION)
TABLE 93. CANADA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 94. CANADA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 95. MEXICO CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 96. MEXICO CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 97. MEXICO CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2019-2027 (USD MILLION)
TABLE 98. MEXICO CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 99. MEXICO CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 100. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 101. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 102. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 103. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2019-2027 (USD MILLION)
TABLE 104. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 105. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 106. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 107. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 108. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 109. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2019-2027 (USD MILLION)
TABLE 110. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 111. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 112. AUSTRALIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 113. AUSTRALIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 114. AUSTRALIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2019-2027 (USD MILLION)
TABLE 115. AUSTRALIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 116. AUSTRALIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 117. CHINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 118. CHINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 119. CHINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2019-2027 (USD MILLION)
TABLE 120. CHINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 121. CHINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 122. INDIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 123. INDIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 124. INDIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2019-2027 (USD MILLION)
TABLE 125. INDIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 126. INDIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 127. INDONESIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 128. INDONESIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 129. INDONESIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2019-2027 (USD MILLION)
TABLE 130. INDONESIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 131. INDONESIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 132. JAPAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 133. JAPAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 134. JAPAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2019-2027 (USD MILLION)
TABLE 135. JAPAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 136. JAPAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 137. MALAYSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 138. MALAYSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 139. MALAYSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2019-2027 (USD MILLION)
TABLE 140. MALAYSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 141. MALAYSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 142. PHILIPPINES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 143. PHILIPPINES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 144. PHILIPPINES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2019-2027 (USD MILLION)
TABLE 145. PHILIPPINES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 146. PHILIPPINES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 147. SINGAPORE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 148. SINGAPORE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 149. SINGAPORE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2019-2027 (USD MILLION)
TABLE 150. SINGAPORE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 151. SINGAPORE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 152. SOUTH KOREA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 153. SOUTH KOREA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 154. SOUTH KOREA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2019-2027 (USD MILLION)
TABLE 155. SOUTH KOREA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 156. SOUTH KOREA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 157. TAIWAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 158. TAIWAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 159. TAIWAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2019-2027 (USD MILLION)
TABLE 160. TAIWAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 161. TAIWAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 162. THAILAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 163. THAILAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 164. THAILAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2019-2027 (USD MILLION)
TABLE 165. THAILAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 166. THAILAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2019-2027 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 173. FRANCE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 174. FRANCE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 175. FRANCE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2019-2027 (USD MILLION)
TABLE 176. FRANCE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 177. FRANCE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 178. GERMANY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 179. GERMANY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 180. GERMANY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2019-2027 (USD MILLION)
TABLE 181. GERMANY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 182. GERMANY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 183. ITALY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 184. ITALY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 185. ITALY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2019-2027 (USD MILLION)
TABLE 186. ITALY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 187. ITALY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 188. NETHERLANDS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 189. NETHERLANDS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 190. NETHERLANDS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2019-2027 (USD MILLION)
TABLE 191. NETHERLANDS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 192. NETHERLANDS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 193. QATAR CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 194. QATAR CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 195. QATAR CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2019-2027 (USD MILLION)
TABLE 196. QATAR CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 197. QATAR CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 198. RUSSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 199. RUSSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 200. RUSSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2019-2027 (USD MILLION)
TABLE 201. RUSSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 202. RUSSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 203. SAUDI ARABIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 204. SAUDI ARABIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 205. SAUDI ARABIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2019-2027 (USD MILLION)
TABLE 206. SAUDI ARABIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 207. SAUDI ARABIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 208. SOUTH AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 209. SOUTH AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 210. SOUTH AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2019-2027 (USD MILLION)
TABLE 211. SOUTH AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 212. SOUTH AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 213. SPAIN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 214. SPAIN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 215. SPAIN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2019-2027 (USD MILLION)
TABLE 216. SPAIN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 217. SPAIN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2019-2027 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 223. UNITED KINGDOM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 224. UNITED KINGDOM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 225. UNITED KINGDOM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2019-2027 (USD MILLION)
TABLE 226. UNITED KINGDOM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 227. UNITED KINGDOM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 228. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 229. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 230. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 231. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET RANKING
TABLE 232. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SHARE, BY KEY PLAYER, 2021
TABLE 233. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET MERGER & ACQUISITION
TABLE 234. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 235. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 236. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET INVESTMENT & FUNDING
TABLE 237. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 238. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET: LICENSE & PRICING

Companies Mentioned

  • Agilent Technologies
  • Beckman Coulter
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • Biovision
  • Cell Signaling Technology
  • Claremont Biosolutions
  • Covaris
  • G-Biosciences (Geno Technology)
  • Labfreez Instruments Group
  • Merck
  • Microfluidics International Corporation
  • Miltenyi Biotec
  • Norgen Biotek Corp.
  • Nzytech
  • Parr Instrument Company
  • Promega Corporation
  • Promocell
  • Qiagen
  • Qsonica
  • Roche Diagnostics
  • Stemcell Technologies
  • Takara Bio
  • Thermo Fisher Scientific

Methodology

Loading
LOADING...